For the treatment of iron deficiency in the following:

• Where there is a clinical need to deliver iron rapidly to iron stores.
• Patients who cannot tolerate oral iron therapy or who are noncompliant.
• In active inflammatory bowel disease where oral iron preparations are ineffective.
• Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients receiving an erythropoietin.
• Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients not receiving an erythropoietin.
• Hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin.
• Peritoneal dialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin.